Dr. Deeks has been engaged in HIV research and clinical care since 1993. He is a recognized expert on HIV-associated immune dysfunction and its impact on HIV persistence (the “reservoir”) and health during antiretroviral therapy. Dr. Deeks has published over 500 peer-review articles, editorials and invited reviews on these and related topics. He has been the recipient of several NIH grants, and one of the principal investigators of DARE (the Delaney AIDS Research Enterprise), which is an NIH-funded international collaboratory aimed at developing therapeutic interventions to cure HIV infection. He a member of the Board of Directors for the UCSF-based amfAR Institute for HIV Cure Research. He is the co-chair of the “Towards an HIV Cure” International Working Group and a former co-chair of the NIH Office of AIDS Research Toward a Cure Planning Group. He was elected to the American Society for Clinical Investigation (ASCI) and Association of American Physicians (AAP). He is the editor-in-chief of Current Opinion in HIV and AIDS, and serves on the Scientific Advisory Board for Science Translational Medicine and the Advisory Board for EBioMedicine. In addition to his clinical and translational investigation, Dr. Deeks maintains a primary care clinic for HIV infected patients. He a former member of the Office of AIDS Research Advisory Council (ORAC) and of the Department on Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents.